 |
Media Contacts
|
U.S. Journalist and Media
Contact Information
The numbers listed below are for use by professional journalists and members of the media. If you are not a member of the
media and need assistance, we ask that you please contact the company at
1-800-243-0127, Monday through Friday from
8:30 a.m. to 5:00 p.m., excluding holidays.
This contact information is not intended for reporting unexpected drug effects or adverse events for any Boehringer Ingelheim
product. Please report any unexpected effects or product problems to the Drug Information Unit by calling 1-800-542-6257 (option 4).
U.S. Headquarters Contact Information
Boehringer Ingelheim Pharmaceuticals, Inc.
900 Ridgebury Road/P.O. Box 368
Ridgefield, CT 06877
1-800-243-0127
Corporate Press & Media Inquiries
Marybeth McGuire - Corporate
203-798-4801
General Media Inquiries for Product & Pipeline
Kate O'Connor - Public Relations
203-791-6250
Combivent® (ipratropium bromide and albuterol sulfate)
Spiriva® HandiHaler® (tiotropium bromide inhalation powder)
Lara Crissey
203-798-4740
Micardis® (telmisartan) tablets
Mirapex® (pramipexole) tablets
Viramune® (nevirapine) tablets
Anna Moses
203-798-4638
Flomax® (tamsulosin HCl) tablets
Ann Wainright
203-798-4470
International Journalists are asked to contact
Boehringer Ingelheim GmbH
Corporate Division Communications
Binger Strasse 173
D-55216 Ingelheim am Rhein
Germany
Tel: + 49/6132/77-2093
Fax: + 49/6132/77-6601
E-mail: webmaster